Aquestive Therapeutics (AQST)

• Market cap: $533M
• 1 day: 0.95%
• 5 days: 6.25%
• 1 month: 2.16%
• 3 months: 5.46%
• 6 months: -31.56%
• Year to date: -34.11%
• 1 year: 28.4%
• 5 years: 2.16%
• 10 years: -73.52%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Employees: 147